1999
DOI: 10.1016/s0167-0115(99)00008-7
|View full text |Cite
|
Sign up to set email alerts
|

CCK2 receptor antagonists: pharmacological tools to study the gastrin–ECL cell-parietal cell axis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
1

Year Published

1999
1999
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(20 citation statements)
references
References 90 publications
1
18
1
Order By: Relevance
“…Histamine production is diminished by ϳ10% in the presence of the CCK2 blocker proglumide, suggesting that gastrin is active along this pathway. This finding is different than other studies, where in various species histamine is believed to be predominately mediated by gastrin to elevate acid secretion (11,15,19,20). Although we show that this pathway is active in the guinea pig, no other studies have monitored both the direct and indirect gastrin pathways leading to the activation of the parietal cell in one experiment on any species.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…Histamine production is diminished by ϳ10% in the presence of the CCK2 blocker proglumide, suggesting that gastrin is active along this pathway. This finding is different than other studies, where in various species histamine is believed to be predominately mediated by gastrin to elevate acid secretion (11,15,19,20). Although we show that this pathway is active in the guinea pig, no other studies have monitored both the direct and indirect gastrin pathways leading to the activation of the parietal cell in one experiment on any species.…”
Section: Discussioncontrasting
confidence: 99%
“…shown that gastrin stimulation induces histidine decarboxylase to synthesize histamine (11,15,30). ACh is released from postganglionic neurons and stimulates the parietal cells directly via M3 receptors and indirectly via M2 and M4 inhibition of somatostatin secretion (34,35).…”
Section: Studies Utilizing Isolated Ecl Cells and In Vitro Assays Havementioning
confidence: 99%
“…AG-041R, a potent and specific gastrin receptor antagonist (Ding et al, 1997;Chiba et al, 1998;Fukui et al, 1998;Hakanson et al, 1999), was a gift from Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan). NS-398, a specific inhibitor of COX-2 (Futaki et al, 1993a,b;Masferrer et al, 1994;Tsuji et al, 1996), was purchased from Cayman Chemicals (Ann Arbor, MI).…”
Section: Methodsmentioning
confidence: 99%
“…The functionally defined receptors for gastrin include cholecystokinin A receptor, which is discriminating for sulfated CCK 8 ; gastrin/cholecystokinin B (CCKB) receptor, which binds gastrin 17 sulfated and nonsulfated CCK 8 with nearly equal affinities; cholecystokinin C, which is a low-affinity gastrin binding protein; and novel, high-affinity receptors selective for amidated gastrin, processing intermediates of gastrin, or both (Yassin, 1999). We also examined the influences of a gastrin/CCKb receptor antagonist (Ding et al, 1997;Chiba et al, 1998;Fukui et al, 1998;Hakanson et al, 1999) on gastric mucosal expression of cyclooxygenase and gastric mucosal protection.…”
mentioning
confidence: 99%
“…In several rat studies, treatment with CCK2R antagonists caused changes in ECL cell activity, indicating the presence of the receptor on these cells (131,195). Binding and functional studies demonstrated that both CCK1R and CCK2R are present on guinea pig chief cells (91, 389).…”
Section: Stomachmentioning
confidence: 99%